Read More Healthcare Industry News Cochlear (ASX: COH) shares rebound as FY27 guidance tests recovery after historic sell-off Cochlear profit fell 22%, but stronger second-half sales and A$330m-A$350m FY27 guidance sent ASX: COH higher as investors tested the recovery. bySrinathAugust 18, 2026